Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Nosis Biosciences and Daiichi Sankyo Partner to Advance RNA-Based Therapies
Wednesday, March 12, 2025Nosis Biosciences has entered into a research collaboration and option agreement with Daiichi Sankyo The Connexa platform enables RNA medicines to target a wide range of cell types across vital organs such as the heart brain lungs kidneys
Syngene Acquires US Manufacturing Facility to Expand Global Biologics Capabilities
Tuesday, March 11, 2025Syngene International has announced the acquisition of its first biologics facility in the United States The site which includes multiple monoclonal antibody mAbs manufacturing lines was purchased from Emergent Manufacturing Operations Baltimore LLC...
Sun Pharma Announces Acquisition of Checkpoint Therapeutics
Tuesday, March 11, 2025Sun Pharmaceutical Industries has announced an agreement to acquire Checkpoint Therapeutics cSCC is the second most common skin cancer in the US with around million cases annually Key risks include UV exposure and immune suppression
Amaran Biotech Enters into Agreement with Nippon Fine Chemical to Expand CDMO Capabilities
Friday, March 07, 2025Amaran Biotechnology has signed a Memorandum of Understanding MOU with Nippon Fine Chemical The agreement aims to strengthen collaboration in nanoparticlebased drug manufacturing while expanding services across Taiwan
ScPharmaceuticals Receives Approval on FUROSCIX® for Edema Treatment in Chronic Kidney Disease
Friday, March 07, 2025ScPharmaceuticals has announced that the US Food and Drug Administration FDA has approved a supplemental New Drug Application sNDA for FUROSCIX FUROSCIX is designed to support the management of oedema by restoring and maintaining fluid balance
Bioheng Therapeutics Gains Approval for CD7 UCAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukaemia/Lymphoma
Thursday, March 06, 2025Bioheng Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application CTD is a universal CART cell product targeting CD Developed from healthy donor cells it is designed to avoid fra...
Antengene Receives Approval on XPOVIO® (Selinexor) for Multiple Myeloma and Lymphoma Treatment
Wednesday, March 05, 2025Antengene has secured approval from Indonesias National Agency of Drug and Food Control BPOM for its New Drug Application NDA for XPOVIO selinexor XPOVIO is the first orally available selective inhibitor of the nuclear export protein XPO By blocking...
IQVIA Laboratories Advances Clinical Trials with Digital Innovation
Wednesday, March 05, 2025IQVIA Laboratories has launched Site Lab Navigator a suite of solutions designed to automate and streamline laboratory workflows for clinical trial sponsors and investigator sites At the core of this innovation is an eRequisition system that replaces...
WuXi Biologics Launches EffiX™ Platform to Advance Microbial Biologics Production
Tuesday, March 04, 2025WuXi Biologics has launched EffiX a new microbial expression platform designed to improve the production of recombinant proteins and plasmid DNA The EffiX platform is a proprietary microbial expression system developed by WuXi Biologics
Celltrion Receives Approval for Denosumab Biosimilars STOBOCLO® and OSENVELT®
Tuesday, March 04, 2025Celltrion has received approval from the US Food and Drug Administration FDA for its denosumab biosimilars STOBOCLO CTP denosumabbmwo and OSENVELT CTP denosumabbmwo STOBOCLO denosumabbmwo is a receptor activator of NFB ligand RANKL inhibitor
